Beneficient (NASDAQ:BENF) does about 4.49M shares in volume on a normal day but saw 2340458 shares change hands in the recent trading day. The company now has a market cap of 7.76M USD. Its current market price is $1.61, marking a decrease of -14.81% compared to the previous close of $1.89. The 52 week high reached by this stock is $156.80 whilst the lowest price level in 52 weeks is $1.11.
Beneficient (BENF) has a 20-day trading average at $1.3160 and the current price is -98.97% off the 52-week high compared with 45.05% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.8761 and its 200-day simple moving average is $9.3379. If we look at the stock’s price movements over the week, volatility stands at 14.52%, which decreases to 12.39% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 52.15 to suggest the stock is neutral.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 67.8% over the period.
The current price level is 21.51%, -15.96%, and -83.06% away from its SMA20, SMA50, and SMA200 respectively, with the BENF price moving above the 50-day SMA on current market day. Beneficient (BENF) stock is up 30.89% over the week and -21.46% over the past month. Its price is -95.86% year-to-date and -98.61% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -2.58 and 0 for whole year. Expected sales for next quarter are $310k, which analysts say will come at $10.99M for the current fiscal year and next year at $10.99M. In addition, estimates put the company’s current quarterly revenue at an average of $300k.
To reach the target analysts have set, the stock logically needs to grow 67.8 percent from here.
The company has a return on equity of -597.18%. The forward price to earnings ratio is 10.06. The beta has a value of -1.12. Price to sales ratio is 7.61.